Literature DB >> 486292

Determination of viloxazine in plasma by GLC.

T R Norman, G D Burrows, B M Davies, J M Wurm.   

Abstract

1 A gas chromatographic procedure for the determination of viloxazine in therapeutic concentrations in human plasma, with use of a flame ionization detector, is described. 2 The drug is extracted at pH 12 into hexane, back extracted into HCl, re-extracted into hexane after alkalinization of the HCl and derivatized with acetic anhydride. 3 An imipramine-butriptyline mixture is used as an internal standard. The coefficients of variation for a concentration of 0.75 microgram/ml are 9.4% and 13.1% for within day and day to day precision respectively. For a 1.75 micrograms/ml solution the within day precision was 5.7%. 4 The method has been applied to a patient receiving 300 mg/day viloxazine treatment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486292      PMCID: PMC1429776          DOI: 10.1111/j.1365-2125.1979.tb05816.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  A sequential trial of viloxazine (Vivalan) and imipramine in moderately depressed patients.

Authors:  B Davies; S Joshua; G Burrows; C Poynton
Journal:  Med J Aust       Date:  1977-04-09       Impact factor: 7.738

Review 2.  Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-06       Impact factor: 9.546

3.  2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent.

Authors:  K B Mallion; A H Todd; R W Turner; J G Bainbridge; D T Greenwood; J Madinaveitia; A R Somerville; B A Whittle
Journal:  Nature       Date:  1972-07-21       Impact factor: 49.962

4.  Plasma concentration of nortriptyline and clinical response in depressive illness.

Authors:  G D Burrows; B Davies; B A Scoggins
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

5.  Gas-liquid chromatographic estimation in blood of ICI 58 834.

Authors:  D E Case
Journal:  J Pharm Pharmacol       Date:  1973-10       Impact factor: 3.765

6.  Blood level studies with viloxazine hydrochloride in man.

Authors:  P F Bayliss; D E Case
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

7.  The disposition and metabolism of I.C.I. 58,834 (viloxazine) in humans.

Authors:  D E Case; P R Reeves
Journal:  Xenobiotica       Date:  1975-02       Impact factor: 1.908

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.